SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 11, 2026

RLMD

RELMADA THERAPEUTICS, INC.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $923K total
Actionable Insight ▲ Bullish

CEO/CFO cluster buys at RLMD are the strongest insider signal in the dataset per academic literature. With the stock near $4.10-4.25 and institutional holders like Jupiter Topco ($77M) already in, this suggests management sees material upside. Monitor for upcoming pipeline catalysts or partnership announcements that could explain the concentrated buying.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$4.52
T+0 close · Sep 11, 2026 · via day close
Latest settled
−25.00%
T+20 · $3.39 · next T+60 in 20d
Vs SPY
−26.87%
α at T+20
Latest observation
−11.59%
T+46 · FF3 residual α
  1. T+0 · Sep 11 $4.52entry
  2. T+1 · 2mo ago −1.77%α −1.32% · $4.44
  3. T+5 · 2mo ago −8.85%α −8.63% · $4.12
  4. T+20 · 6w ago −25.00%α −26.87% · $3.39
  5. T+46 · todayOpen
  6. T+60 · in 20d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RLMD CEO Sergio Traversa and CFO Maged Shenouda collectively purchased $1.67M of stock in open-market transactions over two days (Sep 9-10), with the CEO buying 200K shares and the CFO buying 200K shares. This is a strong cluster buy signal from both top C-suite executives, representing approximately 0.38% of the company's $434M market cap, which is a modest but notable insider conviction signal for a clinical-stage biotech.

Key Financial Metrics

Direction
buying
Total Value
$1.7M
Insiders
2

Key Facts

  • CEO Sergio Traversa purchased 200,000 shares total ($828K) on Sep 9-10 at $4.10-$4.18
  • CFO Maged Shenouda purchased 200,000 shares total ($844K) on Sep 9-10 at $4.20-$4.25
  • Combined insider purchases of $1.67M represent ~0.38% of RLMD's $434M market cap
  • Both executives bought in open-market transactions, not grants or exercises
  • Recent 30-day insider activity shows 4 buys totaling $1.7M, consistent with this cluster
  • Institutional ownership shows Jupiter Topco ($77M), BlackRock ($51M), Adage Capital ($33M) as top holders

Financial Impact

$1.67M in insider purchases, 0.38% of market cap, modest but high-signal given C-suite cluster

insider ownershipmarket confidence

Risk Factors

  • Clinical-stage biotech with no approved products, binary pipeline risk remains
  • $1.67M is only 0.38% of market cap, so signal strength depends on insider conviction rather than dollar magnitude
  • No specific catalyst disclosed, buying could be valuation-driven rather than event-driven

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RLMD-1789127045139

Track record

11 reports on RLMD

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $3.54 Now $3.61 −1.98% settles Dec 15
  2. Nov 16, 2026today 8-K Neutral 3/10 Entry $4.16 Now $3.61 −13.23% settles Dec 15
  3. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $4.21 Now $3.61 −14.25% settles Dec 14
  4. Sep 11, 20269w ago Insider Cluster Bullish 6/10 Viewing Entry $4.52 to $3.39 Now $3.61 −20.13% ▼ −25.00% −26.87% vs SPY
  5. May 13, 202626w ago S-3ASR Bearish 6/10 Entry $7.42 to $6.65 Now $3.61 +51.35% ▲ +10.38% +9.52% vs SPY
  6. May 12, 202626w ago 8-K Neutral 4/10 Entry $7.49 to $6.52 Now $3.61 −51.80% ▼ −12.95% −12.34% vs SPY
  7. Apr 17, 202630w ago DEFA14A Neutral 3/10 Entry $7.37 to $6.34 Now $3.61 −51.02% ▼ −13.98% −18.18% vs SPY
  8. Apr 3, 202632w ago S-3 Neutral 3/10 Entry $6.90 to $7.41 Now $3.61 −47.68% ▲ +7.39% −1.59% vs SPY
  9. Mar 19, 202634w ago Press Release Bullish 8/10 Entry $6.07 to $7.37 Now $3.61 −40.53% ▲ +21.42% +12.10% vs SPY
  10. Mar 12, 202635w ago Press Release Neutral 3/10 Entry $6.15 to $7.29 Now $3.61 −41.30% ▲ +18.54% +16.56% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 11, 2026